New acetylene based histamine H3 receptor antagonists derived from the marine natural product verongamine
New histamine H3 receptor antagonists were developed using an acetylene moiety as a replacement for the amide-oxime functionality of verongamine. The receptor binding affinities of these compounds were optimized. Ligand 14 demonstrated excellent blood-brain barrier penetration.
References (17)
- et al.
Eur. J. Med. Chem.
(1992) - et al.
Bioorg. Med. Chem. Lett.
(1992) - et al.
Biochem. Pharmacol.
(1992) - et al.
Nature
(1987) - et al.
Prog. Drug Res.
(1995) - et al.
Drugs Future
(1996) - et al.
- et al.
There are more references available in the full text version of this article.
Cited by (15)
Piperidino-hydrocarbon compounds as novel non-imidazole histamine H<inf>3</inf>-receptor antagonists
2002, Bioorganic and Medicinal ChemistryBioactive natural products from marine sources
2001, Studies in Natural Products ChemistryHigh antagonist potency of GT-2227 and GT-2331, new histamine H<inf>3</inf> receptor antagonists, in two functional models
1998, European Journal of PharmacologyChapter 4. Recent Advances in Histamine H <inf>3</inf> Receptor Agents
1998, Annual Reports in Medicinal Chemistry
Copyright © 1998 Published by Elsevier Ltd.